Resources

MS News (Y!)

Syndicate content
multiple-sclerosis - Yahoo! News Search Results
Updated: 12 hours 39 min ago

PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022

Thu, 2013/05/16 - 21:39
NEW YORK, May 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market ...
Categories: News

Research and Markets: Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Thu, 2013/05/16 - 20:49
Research and Markets has announced the addition of the "Laquinimod - Forecast and Market Analysi
Categories: News

Research and Markets: Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Thu, 2013/05/16 - 00:20
Research and Markets has announced the addition of the "Tcelna - Forecast and Market Analys
Categories: News

Research and Markets: Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 23:59
Research and Markets has announced the addition of the "Avonex - Forecast and Market Analys
Categories: News

Research and Markets: BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 23:56
Research and Markets has announced the addition of the "BG-12 - Forecast and Market Analysis
Categories: News

Research and Markets: Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 23:50
Research and Markets has announced the addition of the "Betaseron/Betaferon - Forecast an
Categories: News

Research and Markets: Lemtrada (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 20:36
Research and Markets has announced the addition of the "Lemtrada - Forecast and Market Analysis to
Categories: News

PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 13:55
NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis ...
Categories: News

PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 06:03
NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis ...
Categories: News

PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 05:38
NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis ...
Categories: News

Research and Markets: PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 04:46
Research and Markets has announced the addition of the "PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Ma
Categories: News

Research and Markets: Multiple Sclerosis Partnering 2007-2013 Out Now

Wed, 2013/05/15 - 04:08
Research and Markets has announced the addition of the "Multiple Sclerosis Partnering 2007-2013" report to their offeri
Categories: News

Research and Markets: Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 01:37
Research and Markets has announced the addition of the "Rebif - Forecast and Market Analysis
Categories: News

Research and Markets: NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 01:29
Research and Markets has announced the addition of the "NU-100 - Forecast and Market Analysi
Categories: News

Research and Markets: Masitinib (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wed, 2013/05/15 - 01:13
Research and Markets has announced the addition of the "Masitinib - Forecast and Market Analysis
Categories: News

Stanford: treatment delays multiple sclerosis onset in mice

Tue, 2013/05/14 - 03:54
by Elena Kadvany Researchers from the Stanford University School of Medicine discovered that blocking the expression of a single protein in the brains of mice with a form of multiple sclerosis delays the onset of paralysis.
Categories: News

On May 26th, Quebec Walks for Multiple Sclerosis!

Tue, 2013/05/14 - 03:23
MONTREAL , May 13, 2013 /CNW Telbec/ - For the first time in its history, the MS Walk will be held on the same day in 22 cities in Quebec . The Multiple Sclerosis Society of Canada invites you to mark ...
Categories: News

PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022

Tue, 2013/05/14 - 02:55
NEW YORK, May 13, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis ...
Categories: News

PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022

Tue, 2013/05/14 - 01:20
  NEW YORK, May 13, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis ...
Categories: News

PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

Tue, 2013/05/14 - 00:13
NEW YORK, May 13, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis ...
Categories: News